Global Rilpivirine Market Growth 2023-2029

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Rilpivirine Industry Forecast” looks at past sales and reviews total world Rilpivirine sales in 2022, providing a comprehensive analysis by region and market sector of projected Rilpivirine sales for 2023 through 2029. With Rilpivirine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rilpivirine industry.

This Insight Report provides a comprehensive analysis of the global Rilpivirine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rilpivirine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rilpivirine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rilpivirine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rilpivirine.

The global Rilpivirine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Rilpivirine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Rilpivirine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Rilpivirine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Rilpivirine players cover Janssen Cilag International, Gilead Sciences , ViiV Healthcare, Strides Pharma Science Limited, Pharmacare Limited and Aspen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Rilpivirine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Self-production API
• Outsourcing of API

Segmentation by application

• Hospital
• Clinic
• Drug Center
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Janssen Cilag International
• Gilead Sciences
• ViiV Healthcare
• Strides Pharma Science Limited
• Pharmacare Limited
• Aspen

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rilpivirine market?

What factors are driving Rilpivirine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rilpivirine market opportunities vary by end market size?

How does Rilpivirine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

LIST OF TABLES

Table 1. Rilpivirine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rilpivirine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Self-production API
Table 4. Major Players of Outsourcing of API
Table 5. Global Rilpivirine Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Rilpivirine Sales Market Share by Type (2018-2023)
Table 7. Global Rilpivirine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rilpivirine Revenue Market Share by Type (2018-2023)
Table 9. Global Rilpivirine Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Rilpivirine Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Rilpivirine Sales Market Share by Application (2018-2023)
Table 12. Global Rilpivirine Revenue by Application (2018-2023)
Table 13. Global Rilpivirine Revenue Market Share by Application (2018-2023)
Table 14. Global Rilpivirine Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Rilpivirine Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Rilpivirine Sales Market Share by Company (2018-2023)
Table 17. Global Rilpivirine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rilpivirine Revenue Market Share by Company (2018-2023)
Table 19. Global Rilpivirine Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Rilpivirine Producing Area Distribution and Sales Area
Table 21. Players Rilpivirine Products Offered
Table 22. Rilpivirine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rilpivirine Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Rilpivirine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rilpivirine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rilpivirine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rilpivirine Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Rilpivirine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rilpivirine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rilpivirine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rilpivirine Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Rilpivirine Sales Market Share by Country (2018-2023)
Table 35. Americas Rilpivirine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rilpivirine Revenue Market Share by Country (2018-2023)
Table 37. Americas Rilpivirine Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Rilpivirine Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Rilpivirine Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Rilpivirine Sales Market Share by Region (2018-2023)
Table 41. APAC Rilpivirine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rilpivirine Revenue Market Share by Region (2018-2023)
Table 43. APAC Rilpivirine Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Rilpivirine Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Rilpivirine Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Rilpivirine Sales Market Share by Country (2018-2023)
Table 47. Europe Rilpivirine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rilpivirine Revenue Market Share by Country (2018-2023)
Table 49. Europe Rilpivirine Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Rilpivirine Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Rilpivirine Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Rilpivirine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rilpivirine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rilpivirine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rilpivirine Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Rilpivirine Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Rilpivirine
Table 58. Key Market Challenges & Risks of Rilpivirine
Table 59. Key Industry Trends of Rilpivirine
Table 60. Rilpivirine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rilpivirine Distributors List
Table 63. Rilpivirine Customer List
Table 64. Global Rilpivirine Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Rilpivirine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rilpivirine Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Rilpivirine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rilpivirine Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Rilpivirine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rilpivirine Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Rilpivirine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rilpivirine Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Rilpivirine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rilpivirine Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Rilpivirine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rilpivirine Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Rilpivirine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Janssen Cilag International Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 79. Janssen Cilag International Rilpivirine Product Portfolios and Specifications
Table 80. Janssen Cilag International Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Janssen Cilag International Main Business
Table 82. Janssen Cilag International Latest Developments
Table 83. Gilead Sciences  Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 84. Gilead Sciences  Rilpivirine Product Portfolios and Specifications
Table 85. Gilead Sciences  Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. Gilead Sciences  Main Business
Table 87. Gilead Sciences  Latest Developments
Table 88. ViiV Healthcare Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 89. ViiV Healthcare Rilpivirine Product Portfolios and Specifications
Table 90. ViiV Healthcare Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 91. ViiV Healthcare Main Business
Table 92. ViiV Healthcare Latest Developments
Table 93. Strides Pharma Science Limited Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 94. Strides Pharma Science Limited Rilpivirine Product Portfolios and Specifications
Table 95. Strides Pharma Science Limited Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 96. Strides Pharma Science Limited Main Business
Table 97. Strides Pharma Science Limited Latest Developments
Table 98. Pharmacare Limited Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 99. Pharmacare Limited Rilpivirine Product Portfolios and Specifications
Table 100. Pharmacare Limited Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 101. Pharmacare Limited Main Business
Table 102. Pharmacare Limited Latest Developments
Table 103. Aspen Basic Information, Rilpivirine Manufacturing Base, Sales Area and Its Competitors
Table 104. Aspen Rilpivirine Product Portfolios and Specifications
Table 105. Aspen Rilpivirine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 106. Aspen Main Business
Table 107. Aspen Latest Developments

LIST OF FIGURES

Figure 1. Picture of Rilpivirine
Figure 2. Rilpivirine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rilpivirine Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Rilpivirine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rilpivirine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Self-production API
Figure 10. Product Picture of Outsourcing of API
Figure 11. Global Rilpivirine Sales Market Share by Type in 2022
Figure 12. Global Rilpivirine Revenue Market Share by Type (2018-2023)
Figure 13. Rilpivirine Consumed in Hospital
Figure 14. Global Rilpivirine Market: Hospital (2018-2023) & (K Pcs)
Figure 15. Rilpivirine Consumed in Clinic
Figure 16. Global Rilpivirine Market: Clinic (2018-2023) & (K Pcs)
Figure 17. Rilpivirine Consumed in Drug Center
Figure 18. Global Rilpivirine Market: Drug Center (2018-2023) & (K Pcs)
Figure 19. Rilpivirine Consumed in Other
Figure 20. Global Rilpivirine Market: Other (2018-2023) & (K Pcs)
Figure 21. Global Rilpivirine Sales Market Share by Application (2022)
Figure 22. Global Rilpivirine Revenue Market Share by Application in 2022
Figure 23. Rilpivirine Sales Market by Company in 2022 (K Pcs)
Figure 24. Global Rilpivirine Sales Market Share by Company in 2022
Figure 25. Rilpivirine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Rilpivirine Revenue Market Share by Company in 2022
Figure 27. Global Rilpivirine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Rilpivirine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Rilpivirine Sales 2018-2023 (K Pcs)
Figure 30. Americas Rilpivirine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Rilpivirine Sales 2018-2023 (K Pcs)
Figure 32. APAC Rilpivirine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Rilpivirine Sales 2018-2023 (K Pcs)
Figure 34. Europe Rilpivirine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Rilpivirine Sales 2018-2023 (K Pcs)
Figure 36. Middle East & Africa Rilpivirine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Rilpivirine Sales Market Share by Country in 2022
Figure 38. Americas Rilpivirine Revenue Market Share by Country in 2022
Figure 39. Americas Rilpivirine Sales Market Share by Type (2018-2023)
Figure 40. Americas Rilpivirine Sales Market Share by Application (2018-2023)
Figure 41. United States Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Rilpivirine Sales Market Share by Region in 2022
Figure 46. APAC Rilpivirine Revenue Market Share by Regions in 2022
Figure 47. APAC Rilpivirine Sales Market Share by Type (2018-2023)
Figure 48. APAC Rilpivirine Sales Market Share by Application (2018-2023)
Figure 49. China Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Rilpivirine Sales Market Share by Country in 2022
Figure 57. Europe Rilpivirine Revenue Market Share by Country in 2022
Figure 58. Europe Rilpivirine Sales Market Share by Type (2018-2023)
Figure 59. Europe Rilpivirine Sales Market Share by Application (2018-2023)
Figure 60. Germany Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Rilpivirine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Rilpivirine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Rilpivirine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Rilpivirine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Rilpivirine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Rilpivirine in 2022
Figure 75. Manufacturing Process Analysis of Rilpivirine
Figure 76. Industry Chain Structure of Rilpivirine
Figure 77. Channels of Distribution
Figure 78. Global Rilpivirine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Rilpivirine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Rilpivirine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Rilpivirine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Rilpivirine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Rilpivirine Revenue Market Share Forecast by Application (2024-2029)